Stay updated on PRM-151 Efficacy in IPF Clinical Trial

Sign up to get notified when there's something new on the PRM-151 Efficacy in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRM-151 Efficacy in IPF Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the context of a Phase 2 clinical trial evaluating the efficacy of PRM-151 in subjects with Idiopathic Pulmonary Fibrosis (IPF). This change may be significant for individuals monitoring medical and healthcare-related publications and documentation related to fibrotic diseases.
    Difference
    0.1%
    Check dated 2024-06-06T14:22:17.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying age range, health conditions, and prior treatments required for the study. Previously, this section only indicated that no information was provided.
    Difference
    36%
    Check dated 2024-05-22T20:53:03.000Z thumbnail image
  8. Check
    44 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:58:37.000Z thumbnail image

Stay in the know with updates to PRM-151 Efficacy in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRM-151 Efficacy in IPF Clinical Trial page.